1-3 of 3
Mirza Suljagic, DVM, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Nature of the Antigen Determines Leukemia Development and Behavior in the Eμ-TCL1 Transgenic Mouse Model of CLL

Sara Bennardo, BS, Stefano Iacovelli, BS, Stefania Gobessi, PhD, Mirza Suljagic, DVM, PhD, Daniel Bilbao, PhD, Julia Eckl-Dorna, MD, PhD, Hongsheng Wang, MD, PhD, Richard J. Cornall, MD, PhD, Stephen H Clarke, PhD, Carlo M. Croce, MD, Dimitar G Efremov, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 181.
https://doi.org/10.1182/blood.V120.21.181.181
Published: 2012
Journal Articles

The Syk Inhibitor R788 (FosD) Inhibits Tumor Growth in the TCL1 Transgenic Mouse Model of CLL by Blocking Antigen-Dependent BCR Signaling.

Mirza Suljagic, DVM, PhD, Pablo G Longo, MD, Luca Laurenti, MD, Dimitar G Efremov, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 887.
https://doi.org/10.1182/blood.V114.22.887.887
Published: 2009
Journal Articles

Chronic Lymphocytic Leukemia B-Cells Lack or Express Markedly Reduced Levels of the Phosphatase PHLPP, Which Regulates B-Cell Receptor Induced AKT Activation.

Mirza Suljagic, DVM, PhD, Luca Laurenti, MD, Muhammad Alam, MD, Pablo G Longo, MD, Sami N Malek, MD, Dimitar G Efremov, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2080.
https://doi.org/10.1182/blood.V112.11.2080.2080
Published: 2008